Hetrombopag has demonstrated strong efficacy and a favourable safety profile in children with immune thrombocytopenia, according to newly published clinical findings. The data support the use of the thrombopoietin receptor agonist as an effective second-line treatment option in paediatric patients who do not respond adequately to first-line therapy. Immune thrombocytopenia…
Tag: #AutoimmuneDisease
News
Stem Cell Eye Drops Show Promise for Sjögren’s Dry Eye
A new clinical study has raised cautious optimism for millions suffering from severe dry eye disease, particularly patients with Sjögren’s syndrome who often see limited relief from conventional treatments. Researchers have reported encouraging early results using eye drops derived from umbilical cord mesenchymal stem cells, marking a significant step forward…